Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 22% ± 2% | |
glutamatergic neuron | 3 studies | 24% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 20% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1854.28 | 459 / 459 | 100% | 23.99 | 1118 / 1118 |
ovary | 100% | 1277.64 | 180 / 180 | 100% | 14.87 | 430 / 430 |
stomach | 100% | 1286.54 | 359 / 359 | 100% | 16.99 | 286 / 286 |
esophagus | 100% | 1808.57 | 1444 / 1445 | 100% | 15.86 | 183 / 183 |
lung | 100% | 1621.04 | 577 / 578 | 100% | 19.15 | 1155 / 1155 |
intestine | 100% | 1870.80 | 966 / 966 | 100% | 17.50 | 526 / 527 |
bladder | 100% | 1949.43 | 21 / 21 | 100% | 16.28 | 503 / 504 |
prostate | 100% | 1555.09 | 245 / 245 | 100% | 12.62 | 501 / 502 |
brain | 99% | 964.00 | 2625 / 2642 | 100% | 16.47 | 705 / 705 |
uterus | 100% | 1517.23 | 170 / 170 | 99% | 17.62 | 456 / 459 |
skin | 100% | 1464.80 | 1809 / 1809 | 99% | 17.03 | 467 / 472 |
thymus | 100% | 1533.97 | 652 / 653 | 99% | 13.66 | 599 / 605 |
liver | 100% | 1081.40 | 226 / 226 | 98% | 11.73 | 397 / 406 |
pancreas | 97% | 668.58 | 319 / 328 | 99% | 14.68 | 176 / 178 |
kidney | 99% | 866.47 | 88 / 89 | 97% | 9.83 | 876 / 901 |
adrenal gland | 100% | 924.40 | 258 / 258 | 91% | 7.71 | 209 / 230 |
adipose | 100% | 2201.82 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2922.36 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.81 | 29 / 29 |
spleen | 100% | 1523.76 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 15.90 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.85 | 1 / 1 |
muscle | 100% | 1823.70 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 992.17 | 848 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 9.52 | 76 / 80 |
peripheral blood | 59% | 674.96 | 548 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043484 | Biological process | regulation of RNA splicing |
GO_0006282 | Biological process | regulation of DNA repair |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_1904672 | Biological process | regulation of somatic stem cell population maintenance |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0016607 | Cellular component | nuclear speck |
GO_0033276 | Cellular component | transcription factor TFTC complex |
GO_0140513 | Cellular component | nuclear protein-containing complex |
GO_0000124 | Cellular component | SAGA complex |
GO_0005669 | Cellular component | transcription factor TFIID complex |
GO_0036464 | Cellular component | cytoplasmic ribonucleoprotein granule |
GO_0000123 | Cellular component | histone acetyltransferase complex |
GO_0005634 | Cellular component | nucleus |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TAF5L |
Protein name | TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L (TAF5L) (PCAF-associated factor 65 beta) (PAF65-beta) TATA-box binding protein associated factor 5 like |
Synonyms | PAF65B |
Description | FUNCTION: Functions as a component of the PCAF complex. The PCAF complex is capable of efficiently acetylating histones in a nucleosomal context. The PCAF complex could be considered as the human version of the yeast SAGA complex (Probable). With TAF6L, acts as an epigenetic regulator essential for somatic reprogramming. Regulates target genes through H3K9ac deposition and MYC recruitment which trigger MYC regulatory network to orchestrate gene expression programs to control embryonic stem cell state (By similarity). . |
Accessions | O75529 Q5TDI7 ENST00000366674.1 ENST00000258281.7 [O75529-1] ENST00000366675.3 [O75529-2] |